{"id":47978,"date":"2022-09-05T18:01:58","date_gmt":"2022-09-05T16:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/"},"modified":"2022-09-05T18:01:58","modified_gmt":"2022-09-05T16:01:58","slug":"united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/","title":{"rendered":"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644589\/us-migraine-market-and-competitive-landscape?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=8nqf5g&amp;utm_campaign=1745559+-+United+States+Migraine+Market+Analysis+Report+2022%3A+Pipeline%2C+Epidemiology%2C+Valuations+and+Forecasts%2C+Sales+and+Competitive+Landscape&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;US Migraine Market and Competitive Landscape &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/21\/logo.jpg\"><\/a><\/p>\n<p>\nUS Migraine Market Report provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine drugs sales and competitive landscape in the US.\n<\/p>\n<p>\nThe research is classified into seven sections &#8211; Migraine treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.\n<\/p>\n<p>\n<strong>Research Scope:<\/strong>\n<\/p>\n<ul>\n<li>\nMigraine pipeline: Find out the products in clinical trials for the treatment of Migraine by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products\n<\/li>\n<li>\nMigraine epidemiology: Find out the number of patients diagnosed (prevalence) with Migraine in the US\n<\/li>\n<li>\nMigraine drugs: Identify key products marketed and prescribed for Migraine in the US, including trade name, molecule name, and company\n<\/li>\n<li>\nMigraine drugs sales: Find out the sales revenues of Migraine drugs in the US\n<\/li>\n<li>\nMigraine market valuations: Find out the market size for Migraine drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027\n<\/li>\n<li>\nMigraine drugs market share: Find out the market shares for key Migraine drugs in the US\n<\/li>\n<\/ul>\n<p>\n<strong>Benefits of this Research:<\/strong>\n<\/p>\n<ul>\n<li>\nSupport monitoring and reporting national Migraine market analysis and sales trends\n<\/li>\n<li>\nTrack competitor drugs sales and market share in the US Migraine market\n<\/li>\n<li>\nTrack competitive developments in Migraine market and present key issues and learnings\n<\/li>\n<li>\nSynthesize insights for Migraine market and products to drive business performance\n<\/li>\n<li>\nAnswer key business questions about the Migraine market\n<\/li>\n<li>\nEvaluate commercial market opportunity assessment, positioning, and segmentation for Migraine products\n<\/li>\n<li>\nSupports decision making in R&amp;D to long term marketing strategies\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n1) Migraine Treatments\n<\/p>\n<p>\n2) Migraine Pipeline\n<\/p>\n<p>\n3) US Migraine Epidemiology\n<\/p>\n<p>\n4) Marketed Drugs for Migraine in US\n<\/p>\n<p>\n5) US Migraine Market Size and Forecast\n<\/p>\n<p>\n6) US Migraine Products Sales and Forecast\n<\/p>\n<p>\n7) US Migraine Market Competitive Landscape\n<\/p>\n<p>\n8) Methodology\n<\/p>\n<p>\n<strong>List of Tables<\/strong>\n<\/p>\n<p>\n1. Migraine Phase 3 Clinical Trials, 2022\n<\/p>\n<p>\n2. Migraine Phase 2 Clinical Trials, 2022\n<\/p>\n<p>\n3. Migraine Phase 1 Clinical Trials, 2022\n<\/p>\n<p>\n4. Migraine Epidemiology, US, 2021 &#8211; 2027\n<\/p>\n<p>\n5. Marketed Drugs for Migraine, US, 2021\n<\/p>\n<p>\n6. Migraine Market Size and Forecast ($), US, 2019 &#8211; 2027\n<\/p>\n<p>\n7. Migraine Drugs Sales ($), US, 2019 &#8211; 2027\n<\/p>\n<p>\n<strong>List of Figures<\/strong>\n<\/p>\n<p>\n1. Migraine Epidemiology, US, 2021 &#8211; 2027\n<\/p>\n<p>\n2. Migraine Market Size and Forecast ($), US, 2019 &#8211; 2027\n<\/p>\n<p>\n3. Migraine Drugs Market Share (%), US, 2021\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644589\/us-migraine-market-and-competitive-landscape?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=8nqf5g&amp;utm_campaign=1745559+-+United+States+Migraine+Market+Analysis+Report+2022%3A+Pipeline%2C+Epidemiology%2C+Valuations+and+Forecasts%2C+Sales+and+Competitive+Landscape&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/ohnk4b<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;p&#x72;e&#x73;s&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;&#97;r&#x6b;e&#x74;s&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#114;&#x65;s&#101;&#x61;r&#99;&#x68;&#97;&#x6e;&#x64;&#109;&#x61;&#x72;&#107;&#x65;t&#115;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Migraine Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. US Migraine Market Report provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine drugs sales and competitive landscape in the US. The research is classified into seven sections &#8211; Migraine treatment options, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47978","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Migraine Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. US Migraine Market Report provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine drugs sales and competitive landscape in the US. The research is classified into seven sections &#8211; Migraine treatment options, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-05T16:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-05T16:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/\"},\"wordCount\":438,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005371\\\/en\\\/1561471\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/\",\"name\":\"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005371\\\/en\\\/1561471\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-05T16:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005371\\\/en\\\/1561471\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220905005371\\\/en\\\/1561471\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;US Migraine Market and Competitive Landscape &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. US Migraine Market Report provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine drugs sales and competitive landscape in the US. The research is classified into seven sections &#8211; Migraine treatment options, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-05T16:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape &#8211; ResearchAndMarkets.com","datePublished":"2022-09-05T16:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/"},"wordCount":438,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/","name":"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/21\/logo.jpg","datePublished":"2022-09-05T16:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220905005371\/en\/1561471\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/united-states-migraine-market-analysis-report-2022-pipeline-epidemiology-valuations-and-forecasts-sales-and-competitive-landscape-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"United States Migraine Market Analysis Report 2022: Pipeline, Epidemiology, Valuations and Forecasts, Sales and Competitive Landscape &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47978"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47978\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}